People

Juliet Hull

B. Nurse ATI, MBA MGSM Juliet Hull has an MBA from the Macquarie Graduate School of Management, Sydney Australia, and a Bachelor of Nursing from the Auckland Technical Institute. Juliet has more than twenty years’ experience working in Asia and Pacific markets in Healthcare, in sales, Marketing and leadership. Juliet was the General Manager/Country Director for Johnson & Johnson Medical in New Zealand and has held various roles in Johnson & Johnson in Australia and New Zealand since 2012.

Christopher Horn

B.Com UNSW, FCA  Chris Horn has been involved with TruScreen for a number of years. He is an experienced business executive and has acted in a number of management roles including 20 years as a senior partner of KPMG and its predecessor firms. He is a director of a number of private companies across a broad range of business activities including corporate advisory, financial services, and funds management. Chris is a Commerce graduate from the University of New South Wales, Sydney, Australia and a Fellow of the Institute of Chartered Accountants in Australia and New Zealand. Chris is also the Chair of TruScreen’s Audit, Finance and Risk Committee.

Dr. Dexter Cheung

B Tech (Hons), M. Eng, PhD Dr. Dexter Cheung is an experienced medical device engineer and specialist in product research and development. He is the Research and Development Manager of the respiratory humidification division of Fisher & Paykel Healthcare, an ASX/NZX listed healthcare company. With over 20 Years of experience, Dr. Cheung brings a strong understanding of manufacturing processes and has worked with suppliers and manufacturers across the glove. Dr. Cheung’s technical background is in opto-electronics and expertise in medical device engineering is highly relevant to TruScreen, who’s cervical cancer screening device harnesses opto-electronic signatures for screening results.

Marty Dillon

Martin Dillon, the CEO of TruScreen Group Ltd, skillfully managed the company’s listing on the NZX and oversees its strategic vision. With over 30 years of commercial experience, he has engaged with health and regulatory authorities worldwide. Beyond his professional achievements, Dillon is also recognized for his volunteer work as a surf life saver, earning the Cook Community Award for service to his local community.

Guy Robertson

B. Com (Hons) CA Guy Robertson has a Bachelor of Commerce degree and is a member of the Institute of Chartered Accountants in Australia and New Zealand. Guy has over 30 years of management and leadership experience. He has extensive experience as a finance executive in Australia and Asia across a broad range of industries, in both private and listed companies. Mr Robertson is currently a director of ASX listed Hastings Technology Metals Limited and Metal Bank Limited.

Dr. Jerry Tan

Dr. Tan has extensive knowledge of the TruScreen product and has been involved in establishing the markets in China, Vietnam, Mexico and Indonesia among others, including identification of distributors, product registration, market evaluation, conduct of clinical trials and business development.  Dr Tan is a qualified gynaecologist and has been working with opto-electric screening technology for over two decades and has led the commercialisation of TruScreen since the company’s establishment in 2013.  He oversees the commercial operations of TruScreen globally.

Professor Michael Campion

Professor Michael Campion graduated from the University of New South Wales, Australia in 1977. In 1983 -1984, he undertook further Fellowship training in London and completed a Clinical Research Fellowship in Gynaecological Oncology. He was the Scientific Program Director of the British Society for Colposcopy and Cervical Pathology from 1985 till 1987. In 1986, he received the Victor Bonney Award from the London Obstetrics and Gynaecology Society for his pivotal research into the role of human papillomaviruses in the causation of cervical cancer.

In 1987-1996, Michael took up key research, clinical and academic positions at St. Joseph’s Hospital, the Centres for Disease Control and Macon School of Medicine, Atlanta, Georgia. He established cancer screening projects in developing and underprivileged communities, including Innuit women in Alaska and women in rural Georgia, USA. He was appointed the Scientific Program Director of the American Society for Colposcopy and Cervical Pathology (ASCCP) from 1991 to 1997. In 1997, he returned to Australia to take up the Directorship of the Preinvasive Unit, Gynaecological Cancer Centre, Royal Hospital for Women, Randwick where he continues in this role. A/Prof Campion received number of awards for clinical research including the ASCCP Meritorious Service Award in 1994 and the ASCCP Meritorious Award for Scientific Achievement in 1996. In 2006, he was awarded a Chief of Army Commendation for his service in saving lives in Bougainville, East Timor and Banda Aceh.

As a Colonel in the Royal Australian Army Medical Corps, Michael Campion is currently the Director, Health Services Army Reserve NSW/ACT, the Army representative on the Regional Health Advisory Group and the Senior Health Advisor (Army) to Joint Health Command. In 2010, A/Prof Campion received the Lifetime Achievement Award from Warrane College, University of New South Wales for his gynecological service to the indigenous and non-indigenous population of rural and remote New South Wales. He has published over sixty academic papers, articles, book and book chapters and presented at numerous scientific congresses.

Prof. Neville Hacker

Professor Neville Hacker AM did his initial training in Brisbane. In 1978, he moved to the University of California, Los Angeles (UCLA) to train in Gynaecological Oncology. He rose to become the Director of Gynaecological Oncology at UCLA in 1984, before returning to Australia to establish Australia’s first multidisciplinary Gynaecological Cancer Centre at the Royal Hospital for Women in Sydney in late 1986. He is a Past President of the International Gynecological Cancer Society, a Past President of the Society of Pelvic Surgeons, and a past member of the Cancer Committee of FIGO. He has written over 250 peer reviewed scientific papers, and is co-editor of Berek and Hacker’s Gynecologic Oncology, now in its 7^th edition.

Prof Sean Kehoe

Prof Sean Kehoe qualified at Trinity College Dublin and after obtaining his MRCOG came to the UK and took the post of CRC Fellow in Gynaecological Cancer at the University of Birmingham. He obtained an MD, and continued to work in Birmingham achieving subspecialty training in Gynaecological Oncology and was appointed a Senior Lecturer in Gynaecological Cancer. He then moved to Oxford and as the Foundation Professor of Gynaecological Cancer he developed the Oxford Gynaecological Cancer Centre before returning to Birmingham to take up the Lawson Tait Chair in Gynaecological Cancer in December 2012. He has lectured widely both nationally and internationally. In 2010 he was awarded the Boyle Memorial Medal by the Institute of Obstetricians and Gynaecologists of Ireland and was re-elected a Senior Research Fellow of St Peters in 2013.

Prof. Neville Hacker

Professor Neville Hacker AM did his initial training in Brisbane. In 1978, he moved to the University of California, Los Angeles (UCLA) to train in Gynaecological Oncology. He rose to become the Director of Gynaecological Oncology at UCLA in 1984, before returning to Australia to establish Australia’s first multidisciplinary Gynaecological Cancer Centre at the Royal Hospital for Women in Sydney in late 1986. He is a Past President of the International Gynecological Cancer Society, a Past President of the Society of Pelvic Surgeons, and a past member of the Cancer Committee of FIGO. He has written over 250 peer reviewed scientific papers, and is co-editor of Berek and Hacker’s Gynecologic Oncology, now in its 7^th edition.

Hextan Yuen Sheung Ngan

Prof Ngan graduated in the University of Hong Kong in 1978. She obtained MD in 1995 and FRCOG in 1996. She has been a gynaecological oncologist accredited by the Royal College of Obstetricians and Gynaecologists (RCOG) since 1993, and has vast experience in open, laparoscopic and robot-assisted cancer surgery. She has got more than 400 publications in peer-review journals. Her research interest is in biomolecular studies, cancer screening, clinical trials and psychosocial studies in gynaecological oncology. Prof Ngan is the past president of the Hong Kong College of Obstetricians and Gynaecologists (HKCOG), past president of the Asia Oceania Research Organization of Genital Infections & Neoplasia (AOGIN), past Chair of the FIGO Gynecology Oncology Committee, and currently the President of the Family Planning Association of Hong Kong. She was the Head of Department of Obstetrics & Gynaecology (1/2009-6/2021), the University of Hong Kong, and had been endowed with Tsao Yin-Kai Professorship in Obstetrics and Gynaecology in 2009 (1/2009-6/2021). Prof Ngan was also the head of the gynaecological oncology team and laboratory of the Department of OG, University of Hong Kong (2003-2020) and Chair of Specialty for Obstetrics & Gynaecology, Gleneagles Hong Kong Hospital Limited (6/2015-6/2021). She is the Chief of Service in Obstetrics & Gynaecology of the University of Hong Kong-Shenzhen Hospital since 7/2012. Research and conference grants award: Over 30 grants awarded (As primary investigators) Over 80 grants awarded (As co-investigators)

Salim Abraham Barquet-Muñoz MSc

Dr. Barquet is a Gynecologist Oncologist and is part of the staff of the gynecology department of the National Cancer Institute of Mexico City as coordinator of the Dysplasia Clinic and the Young Woman with Cancer Clinic. He has written several peer review articles and book chapters related to gynecology oncology. He is also a member of the National System of Researchers of Mexico and is a professor of the Oncology Gynecology residency program.

Dr. Chibuike Chigbu

Dr Chigbu is a consultant gynaecological oncologist at the University of Nigeria Teaching Hospital, Ituku-Ozalla Enugu, Nigeria and heads the cervical cancer prevention unit of the Teaching Hospital. He is a member of the West African Health Organization expert consultative group on cervical cancer prevention. He is also the Associate Director of the Institute of Maternal and Child Health, University of Nigeria Nsukka and the head of the Female Reproductive Health Oncology Research Group of the University. Dr Chigbu has written numerous peer-reviewed papers and book chapters on cervical cancer prevention.

Prof. Jonathan S. Berek

MD, MMSc Jonathan S. Berek MD, MMSc is the Laurie Kraus Lacob Professor at the Stanford University School of Medicine and a past Fellow in the Stanford Distinguished Careers Institute. He helped establish and is the Director of the Stanford Women’s Cancer Center, which is one of the first programs in the nation to combine breast & gynecologic oncology with a women’s cancer translational research, genetics and supportive services programs. He serves as Senior Advisor, Stanford Cancer Institute, and was Chair of the Stanford Department of Obstetrics and Gynecology from 2005-2017. An author and editor, Dr. Berek has published over 350 peer-reviewed manuscripts in the scientific literature, and numerous book chapters and monographs. His books, Berek & Hacker’s Gynecologic Oncology, 7th edition, and Berek & Novak’s Gynecology, 16th edition, are leading texts in the field. He is the Editor-in-Chief of Current Opinion in Obstetrics & Gynecology.